Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Acta Neuropsychiatrica|January 19, 2022
Monitoring of COVID-19 pandemic-related psychopathology using machine learningKenneth C Enevoldsen, Andreas A Danielsen, Christopher Rohde, et al.Acta Neuropsychiatrica|August 24, 2023
Lexical stability of psychiatric clinical notes from electronic health records over a decadeLasse Hansen, Kenneth Enevoldsen, Martin Bernstorff, et al.Acta Oto-Laryngologica|July 1, 1996
Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Clinical relevance and relation to allergyA Davidsson, A Danielsen, G Viale, et al.Human Mutation|September 11, 2008
Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- statusStine A Danielsen, Guro E Lind, Merete Bjørnslett, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 1, 1993
Serum immunoglobulin G subclasses and serum immunoglobulin A in acute bronchiolitis in infantsK H Carlsen, O J Mellbye, P Fuglerud, et al.The Journal of Pathology|January 15, 2009
Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumoursIrene Bottillo, Terje Ahlquist, Helge Brekke, et al.Neoplasia (New York, N.Y.)|July 2, 2008
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1ATerje Ahlquist, Irene Bottillo, Stine A Danielsen, et al.Oncogenesis|September 18, 2013
Epigenetic and genetic features of 24 colon cancer cell linesD Ahmed, P W Eide, I A Eilertsen, et al.Oncogene|July 17, 2019
Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gainsKaja C G Berg, Anita Sveen, Maren Høland, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2018
CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancerJ Smeby, A Sveen, M A Merok, et al.Pageof 5